A carregar...

Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia

Inhibitors of cyclin-dependent kinases (Cdks) have been reported to have activities in chronic lymphocytic leukemia cells by inhibiting Cdk7 and Cdk9, which control transcription. Here we studied the novel Cdk inhibitor SNS-032, which exhibits potent and selective inhibitory activity against Cdk2, C...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chen, Rong, Wierda, William G., Chubb, Sherri, Hawtin, Rachael E., Fox, Judith A., Keating, Michael J., Gandhi, Varsha, Plunkett, William
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2680368/
https://ncbi.nlm.nih.gov/pubmed/19234140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-12-190256
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!